Comperative analysis neurological symptoms with application haloperidol and risperidone in patients with schizophrenia

  • І. R. Romash Ivano-Frankivsk National Medical University, Ivano-Frankivsk, Ukraine
Keywords: atypical antipsychotics, schizophrenia, extrapyramidal disorders.

Abstract

We show comparative analysis of complications neurological systems in patients with schizophrenia treated with typical antipsychotic haloperidol and atypical antipsychotic risperidone. It is established, that the application of haloperidol was significantly more common found following symptoms like tremor, acute dystonia and involuntary rhythmic movements of the tongue, compared with the group of patients treated with risperidone. When used haloperidol frequently observed severe anxiety. In patients treated with risperidone, more frequent found moderate abnormal involuntary movements.

Downloads

Download data is not yet available.

References

Бурчинский С. Г. Проблема выбора атипичного нейролептика: клинико-психофармакологические аспекты // Укр. вісн. психоневрології. – 2012. – Т. 20, Вип. 4. – С. 79–83.

Вильянов В.Б., Гамбург А. Л., Резникова Т. П. Сравнительная эффективность клопиксола, флюанксола и рисперидона при лечении обострений параноидной шизофрении // Соц. и клин. психиатрия. – 2002. – Т. 12, № 3.– С. 61–64.

Гиляров М. Ю. Аритмогенный эффект антипсихотических лекарственных средств // Там же. – 2002. – Т. 12, № 3. – С. 65–71.

Мосолов С. Н. Современная антипсихотическая фармакотерапия шизофрении // Рус. мед. журн. – 2004. – Т. 12, № 10. – С. 23–28.

Соловьёва Е. Ожирение у пациентов с тяжёлыми психическими расстройствами (обзор) // НейроNews. – 2010. – Вып. 27, № 8. – C. 12–15.

Gardner David M., Baldessarini Ross J., Waraich Paul. Modern antipsychotic drugs: a critical overview // CCMAJ. – 2005. – Vol. 172, N 13. – P. 1703–1711.

Geddes J. R.,Carney S. M., Davies C. Relapse prevention with antidepressant drug treatment in depressive disorders: a systematic review // Lancet. – 2003. – Vol. 361. – P. 653–661.

Green M. F., Kern R. S., Robertson M. J., Sergi M. J. Relevance of neurocognitive deficits for functional outcome in schisophrenia.In cognition in schizophrenia:impair ments.importance and treatment strategies / Еd. T. Sharma and P. Harvey. – New York: Oxford University Press., 2000. – P. 178–192.

Leucht S., Tardy M., Komossa K. Maintenance treatment with antipsychotic drugs for schizophrenia // Cochrane Database Syst Rev. – 2012. – Vol. 16, N 5. – P. 1008–1016.

Rummel-Kluge C.,Komossa K., Schwarz S. et al. Head-to-head comparisons of metabolic side effects of second generation antipsychotics in the treatment of schizophrenia: a systematic review and metaanalysis // Schizophrenia Research. – 2010. – Vol. 123, N 2–3. – P. 225–233.


Abstract views: 21
PDF Downloads: 26
Published
2016-06-03
How to Cite
RomashІ. R. (2016). Comperative analysis neurological symptoms with application haloperidol and risperidone in patients with schizophrenia. Likars’ka Sprava, (3-4), 81-86. https://doi.org/10.31640/LS-2016(3-4)13
Section
Guide lines for the practitioner